Bank of New York Mellon
THRN

Bank of New York Mellon’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Bank of New York Mellon’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-77,948
Closed -$794K – 4449
2023
Q3 		$794K Buy
77,948
+538
+0.7% +$4.1K ﹤0.01% 3301
2023
Q2 		$364K Buy
77,410
+12,259
+19% +$56.3K ﹤0.01% 3751
2023
Q1 		$301K Hold
65,151
– – ﹤0.01% 3739
2022
Q4 		$236K Sell
65,151
-71
-0.1% -$315 ﹤0.01% 3902
2022
Q3 		$308K Buy
65,222
+4,313
+7% +$21.7K ﹤0.01% 3822
2022
Q2 		$295K Buy
60,909
+46,226
+315% +$281K ﹤0.01% 3888
2022
Q1 		$93K Buy
+14,683
New +$79K ﹤0.01% 4420

Bank of New York Mellon's THRN Position: Q4 2023 in Review

Bank of New York Mellon sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 77,948 shares — an estimated $794K sold.

Bank of New York Mellon first reported a position in THRN in Q1 2022 and held it in 7 quarters. The position peaked at $794K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

  • Bank of New York Mellon reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 77,948 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $794K.
  • Bank of New York Mellon first reported a position in Thorne Healthtech, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Bank of New York Mellon's Thorne Healthtech, Inc. Common Stock position peaked at $794K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.